Is there correlation between the BAL and induced sputum principal phospholipids level in sarcoidosis? Source: Eur Respir J 2003; 22: Suppl. 45, 84s Year: 2003
Induced sputum TNF-α level as possible prognostic factor in sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 115s Year: 2007
The contribution of serum ferritin, iron, iron binding capacity and bronchoalveolar lavage ferritin levels in differential diagnosis of lung cancer from benign pulmonary diseases Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies Year: 2007
Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis? Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004
Comparison of tumour markers in induced sputum and serum Source: Eur Respir J 2004; 24: Suppl. 48, 76s Year: 2004
Serum lipid levels in patients with bronchiectasis Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008
Lipid metabolite levels recovered from BAL fluid correlate with lung function of COPD patients and controls Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008
Usefulness of serum procalcitonin in lung cancer patients with elevated serum C-reactive protein level Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011
Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis Source: Annual Congress 2004 - Fibrosing lung diseases Year: 2004
Increased levels of hyaluronan in induced sputum from COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003
The investigation of diagnostic value of serum reactive protein (CRP) in patients with pleural effusion Source: Eur Respir J 2006; 28: Suppl. 50, 374s Year: 2006
Pleural fluid and plasma D-dimer levels tuberculous pleurisy: the diagnostic value and relation with clinical parameters Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections Year: 2009
CEA levels in the serum and induced sputum of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 324s Year: 2005
Serum total cholesterol, HDL-C and LDL-C levels significantly correlate with the radiological extent of disease and the degree of smear positivity in patients with pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 860s Year: 2006
Increased fraction of small round lymphocyte in BALF is a diagnostic indicator for sarcoidosis Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020
Increased levels of osteopontin in sputum supernatant in patients with COPD Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012
The influence of the COPD exacerbation treatment on the MMP-9 concentration in serum, induced sputum and BAL Source: Eur Respir J 2005; 26: Suppl. 49, 298s Year: 2005
High serum procalcitonin and C-reactive protein levels can exclude tuberculosis in community-acquired pneumonia patients with atypical presentation Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010
Relationship between total IgE in induced sputum and serum Source: Eur Respir J 2002; 20: Suppl. 38, 509s Year: 2002
Prognostic role of CCL18 serum concentrations in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007